Navigation Links
BioNano Genomics Appoints Dr. Fahim Amini As Vice President Commercial Operations EMEA
Date:5/31/2013

SAN DIEGO, May 31, 2013 /PRNewswire/ -- BioNano Genomics, the developer of the Irys™ System for genome mapping, announced today the appointment of Fahim Amini , Ph.D. as vice president, Commercial Operations EMEA. Dr. Amini will further expand BioNano's commercial reach for the Irys System, making it possible for researchers and clinicians in Europe, Middle East and Africa to access BioNano's recently launched Irys platform.

"As we prepare to expand access to the Irys System globally into Europe and beyond, we are looking forward to meeting the needs of researchers and clinicians who require deeper insights into genome variations," said Todd Dickinson , Ph.D., vice president, Global Commercial Operations. "Fahim's addition to the team at BioNano Genomics is a key component of our commercial roll-out in Europe. Fahim has a proven track record in supporting labs in Europe, big and small, in the successful adoption of new platforms for genome analysis."

"This is an exciting time in genomics research, especially with a commercial system that will propel the field of genomics, with all its tremendous advances in the recent years, to the next level," said Dr. Amini.  "It is widely known that detecting structural variation and penetrating difficult repetitive regions with today's short and medium-read technologies has been challenging.  By preserving the native genomic structure, the Irys System allows new insights to be gained through direct visualization of genome structure, enabling the detection of structural variation, significantly improving genome assemblies, phasing haplotypes, and many other applications yet to be developed. I am eager to help resea
'/>"/>

SOURCE BioNano Genomics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology news :

1. Mount Sinai Selects Exemplar LIMS for Genomics Core Facility
2. BGI hosts its 2nd International Conference on Genomics in the Americas
3. New supercomputer to aid genomics research
4. Nurses at forefront of genomics in healthcare
5. The 2013 International Conference on Genomics in Europe will take place in Ghent, Belgium
6. Big genomics data, big scientific impact: New challenges for further development of life science
7. Bridging the gap between genomics and education
8. Ontario Genomics Institute invests in validation of a novel protein interaction technology at U of T
9. New genomics study shows ancestry could help solve disease riddles
10. Physiological Genomics journal announces a major restructuring
11. 2 pioneering plant genomics efforts given a funding boost by National Science Foundation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2014)... ability to switch out one gene for another in ... from science fiction to reality within this decade. As ... promise--the hope of fixing disease-causing genes in humans, for ... scientists have put one of those concerns to rest: ... overall occurrence of mutations in the cells. The new ...
(Date:7/9/2014)... Sexual selection refers to species, selection for traits ... type of natural selection enhances opportunities to mate, the ... Biologists at the University of California, Riverside have now ... of a placenta are linked. Describing the life ... the family Poeciliidae, the researchers found that species with ...
(Date:7/9/2014)... Cancer Genome Atlas (TCGA) Research Network have identified ... lung adenocarcinoma, the most common subtype of lung ... the number of possible therapeutic targets for this ... patients with treatable mutations because many potent cancer ... TCGA is jointly funded and managed by the ...
Breaking Biology News(10 mins):No extra mutations in modified stem cells, study finds 2No extra mutations in modified stem cells, study finds 3Biologists link sexual selection and placenta formation 2Biologists link sexual selection and placenta formation 3Biologists link sexual selection and placenta formation 4Study identifies novel genomic changes in the most common type of lung cancer 2Study identifies novel genomic changes in the most common type of lung cancer 3
... from the Andes in Colombia to the Atlantic in ... plains of the Llanos and the Guiana shield ... 3rd most important river system on the planet, and one of ... has shown a strong commitment to the achievement of the ...
... citizens negotiated the tensions following the March 4 nationwide ... 2007 vote weighed heavily for many reasons. Among those ... of a new paper in AIDS Reviews , ... do to public health by disrupting treatment and thereby ...
... is an exotic plant originating from the Ukraine and ... Ontario, Canada. It has been found growing successfully in ... edges and understories, parks, road edges and railway embankments. ... large and dense stands that climb over other plants. ...
Cached Biology News:The natural ecosystems in the Colombian Orinoco Basin are in danger 2Political strife undermines HIV treatment 2Political strife undermines HIV treatment 3A European invader outcompetes Canadian plants even outside its usual temperature range 2
(Date:1/14/2014)... Bellingham, Washington, USA, and Cardiff, UK (PRWEB) January 13, ... and photonics technology development leader with more than 20 ... international society for optics and photonics . Hainsey will ... “We are delighted to have Dr. Hainsey join SPIE ...
(Date:1/14/2014)... NY (PRWEB) January 14, 2014 During the ... now known as “The Doctor’s Plague.” In this time period, ... hands. This led, at times, to the death of vulnerable ... today don’t know that they may be unwittingly transmitting herpes ...
(Date:1/14/2014)... January 14, 2014 BioMedomics, Inc. , ... POC diagnostic platforms and novel disease specific POC tests, announced ... financing netting a total of $690,000. The investment is from ... the company. This group of private investors has significant successful ...
(Date:1/14/2014)... Translational Biosciences, a subsidiary of ... trial approval for the treatment of rheumatoid arthritis ... from the Comité Nacional de Bioética de la ... (RA) is an autoimmune disease in which the ...
Breaking Biology Technology:Photonics R&D Leader Bob Hainsey Joins SPIE Technical Staff 2Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 2Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 3BioMedomics, Inc. Closes $690K Round of Financing 2Panama’s First Umbilical Cord Stem Cell Clinical Trial for Rheumatoid Arthritis Approved by Comité Nacional de Bioética de la Investigación Institutional Review Board 2Panama’s First Umbilical Cord Stem Cell Clinical Trial for Rheumatoid Arthritis Approved by Comité Nacional de Bioética de la Investigación Institutional Review Board 3
... -- Sinovac Biotech Ltd.,(NYSE Alternext US: SVA), ... today,announced its wholly owned subsidiary, Tangshan Yian ... China,s Ministry of Agriculture to,conduct field trials ... with independent intellectual property rights. With this ...
... 26 MAP,Pharmaceuticals, Inc. (Nasdaq: MAPP ) ... efficacy portion of its initial Phase 3 clinical,trial evaluating ... acute treatment of migraine. , ... potential to be,both fast acting and long-lasting, providing pain ...
... second of its "next-generation" health and longevity products ... cardiovascular healthNEW YORK, Jan. 26 AIM Pharmakon, ... the introduction of the next generation of health ... premium-quality liquid calcium mineral concentrate for bone development ...
Cached Biology Technology:Sinovac Enters Veterinary Vaccine Market with Inactivated Rabies Vaccine 2Sinovac Enters Veterinary Vaccine Market with Inactivated Rabies Vaccine 3Sinovac Enters Veterinary Vaccine Market with Inactivated Rabies Vaccine 4MAP Pharmaceuticals Announces Completion of Enrollment in Phase 3 Clinical Trial of MAP0004 in Patients with Migraine 2MAP Pharmaceuticals Announces Completion of Enrollment in Phase 3 Clinical Trial of MAP0004 in Patients with Migraine 3AIM Pharmakon (API) Announced a New Proprietary Premium-Quality Natural Concentrated Liquid Calcium and Mineral Supplement Now Available Direct to Consumers 2AIM Pharmakon (API) Announced a New Proprietary Premium-Quality Natural Concentrated Liquid Calcium and Mineral Supplement Now Available Direct to Consumers 3AIM Pharmakon (API) Announced a New Proprietary Premium-Quality Natural Concentrated Liquid Calcium and Mineral Supplement Now Available Direct to Consumers 4
One-step, microplate or cuvet, colorimetric, detection range 0.78 ug/dL to 65 ug/dL Zn in serum, plasma, urine, saliva etc. Procedure: 10 min....
Zebrafish Ephrin-B2 Biotinylated Affinity Purified PAb...
... Customer Peptide Synthesis , Containing one Phospho-Amino Acid ... returned to customer conjugation of peptide to KLH protein , ... 102 days/each , Pre-immune bleed x1 /each ... Test bleed (app. 5 ml) x1 /each ...
The Varian 4000 GC/MS system offers three easily switchable ionization configurations: internal ionization (II), external ionization (EI) or hybrid chemical ionization (CI)...
Biology Products: